Prescription Drug Information: Lidocaine Hydrochloride (Page 3 of 3)

PRINCIPAL DISPLAY PANEL — 20 mg/mL Syringe Carton — LIFESHIELD

5 mL

NDC 0409-4903-11

Intravenous For
Cardiac Arrhythmias

2%
Lidocaine
HCl
Inj., USP

100 mg/5 mL
(20 mg/mL)

LIFESHIELD®

Glass
ABBOJECT®
Unit of Use Syringe

with male luer lock
adapter and 20-Gauge
protected needle

100 mg
TOTAL

LOT ##-###-AA EXP DMMMYYYY

Rx only

Hospira

◀ PRESS AND PULL TO OPEN

PRINCIPAL DISPLAY PANEL -- 20 mg/mL Syringe Carton -- LIFESHIELD
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 10 mg/mL Syringe Label — LIFESHIELD

5 mL Single-dose
NDC 0409-4904-11
Rx only

1% Lidocaine
HCl Injection, USP
50 mg/5 mL (10 mg/mL)

Contains no preservatives. See insert for dosage.
Sterile, nonpyrogenic. I.V. for cardiac arrhythmias.

Distributed by Hospira, Inc., Lake Forest, IL 60045 USA

Hospira

RL-7649

PRINCIPAL DISPLAY PANEL -- 10 mg/mL Syringe Label -- LIFESHIELD
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 10 mg/mL Syringe Carton — LIFESHIELD

5 mL

NDC 0409-4904-11

Intravenous For
Cardiac Arrhythmias

Lidocaine
HCl
Injection, USP
1%

50 mg/5 mL
(10 mg/mL)

LIFESHIELD®

Glass
ABBOJECT®
Unit of Use Syringe

with male luer lock adapter
and 20-Gauge protected needle

50 mg
TOTAL

Rx only

LOT ##-###-AA EXP DMMMYYYY

Hospira

◀ PRESS AND PULL TO OPEN

PRINCIPAL DISPLAY PANEL -- 10 mg/mL Syringe Carton -- LIFESHIELD
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 20 mg/mL Syringe Label

5 mL Single-dose syringe
NDC 0409-1323-15

2% Lidocaine HCl Injection, USP
100 mg/5 mL (20 mg/mL)
Rx only

Intravenous use for Ventricular Arrhythmias.
pH ( 5.0 to 7.0 ).

Hospira

Distributed by Hospira, Inc., Lake Forest, IL 60045 USA

RL-7647

PRINCIPAL DISPLAY PANEL -- 20 mg/mL Syringe Label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 20 mg/mL Syringe Carton

5 mL

NDC 0409-1323-15
Rx only

Intravenous use for
Ventricular Arrhythmias

2%
Lidocaine
HCl
Injection, USP

100 mg/5 mL
(20 mg/mL)

Ansyr™

Single-dose
syringe

100 mg
TOTAL

Preservative Free

LOT ##-###-AA EXP DMMMYYYY

Hospira

◀ PRESS AND PULL TO OPEN ▶

PRINCIPAL DISPLAY PANEL -- 20 mg/mL Syringe Carton
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 10 mg/mL Syringe Label

5 mL Single-dose syringe
NDC 0409-9137-11

1% Lidocaine HCl Injection, USP
50 mg/5 mL (10 mg/mL)
Rx only

Intravenous use for Ventricular Arrhythmias.
pH ( 5.0 to 7.0 ).

Hospira

Distributed by Hospira, Inc., Lake Forest, IL 60045 USA

RL-7650

PRINCIPAL DISPLAY PANEL -- 10 mg/mL Syringe Label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 10 mg/mL Syringe Carton

5 mL

NDC 0409-9137-11
Rx only

Intravenous use for
Ventricular Arrhythmias

1%
Lidocaine
HCl
Injection, USP

50 mg/5 mL
(10 mg/mL)

Ansyr™

Single-dose
syringe

50 mg
TOTAL

Preservative Free

LOT ##-###-AA EXP DMMMYYYY

Hospira

◀ PRESS AND PULL TO OPEN ▶

PRINCIPAL DISPLAY PANEL -- 10 mg/mL Syringe Carton
(click image for full-size original)
LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride injection, solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0409-4903
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LIDOCAINE HYDROCHLORIDE (LIDOCAINE) LIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
SODIUM HYDROXIDE
HYDROCHLORIC ACID
SODIUM CHLORIDE
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0409-4903-34 10 CARTON in 1 CONTAINER contains a CARTON
1 1 SYRINGE in 1 CARTON This package is contained within the CONTAINER (0409-4903-34) and contains a SYRINGE (0409-4903-11)
1 NDC:0409-4903-11 5 mL in 1 SYRINGE This package is contained within a CARTON and a CONTAINER (0409-4903-34)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA083158 12/01/2005
LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride injection, solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0409-4904
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LIDOCAINE HYDROCHLORIDE (LIDOCAINE) LIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
SODIUM HYDROXIDE
HYDROCHLORIC ACID
SODIUM CHLORIDE
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0409-4904-34 10 CARTON in 1 CONTAINER contains a CARTON
1 1 SYRINGE in 1 CARTON This package is contained within the CONTAINER (0409-4904-34) and contains a SYRINGE (0409-4904-11)
1 NDC:0409-4904-11 5 mL in 1 SYRINGE This package is contained within a CARTON and a CONTAINER (0409-4904-34)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA083158 08/30/2005
LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride injection, solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0409-1323
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LIDOCAINE HYDROCHLORIDE (LIDOCAINE) LIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
SODIUM HYDROXIDE
HYDROCHLORIC ACID
SODIUM CHLORIDE
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0409-1323-05 10 CARTON in 1 CONTAINER contains a CARTON
1 1 SYRINGE, PLASTIC in 1 CARTON This package is contained within the CONTAINER (0409-1323-05) and contains a SYRINGE, PLASTIC (0409-1323-15)
1 NDC:0409-1323-15 5 mL in 1 SYRINGE, PLASTIC This package is contained within a CARTON and a CONTAINER (0409-1323-05)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA040302 12/09/2005
LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride injection, solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0409-9137
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LIDOCAINE HYDROCHLORIDE (LIDOCAINE) LIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
SODIUM HYDROXIDE
HYDROCHLORIC ACID
SODIUM CHLORIDE
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0409-9137-05 10 CARTON in 1 CONTAINER contains a CARTON
1 1 SYRINGE, PLASTIC in 1 CARTON This package is contained within the CONTAINER (0409-9137-05) and contains a SYRINGE, PLASTIC (0409-9137-11)
1 NDC:0409-9137-11 5 mL in 1 SYRINGE, PLASTIC This package is contained within a CARTON and a CONTAINER (0409-9137-05)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA040302 07/06/2005
Labeler — Hospira, Inc. (141588017)
Establishment
Name Address ID/FEI Operations
Hospira, Inc. 093132819 ANALYSIS (0409-1323), ANALYSIS (0409-4903), ANALYSIS (0409-4904), ANALYSIS (0409-9137), MANUFACTURE (0409-1323), MANUFACTURE (0409-4903), MANUFACTURE (0409-4904), MANUFACTURE (0409-9137), PACK (0409-1323), PACK (0409-4903), PACK (0409-4904), PACK (0409-9137), LABEL (0409-1323), LABEL (0409-4903), LABEL (0409-4904), LABEL (0409-9137)
Establishment
Name Address ID/FEI Operations
Hospira, Inc. 827731089 ANALYSIS (0409-1323), ANALYSIS (0409-4903), ANALYSIS (0409-4904), ANALYSIS (0409-9137)

Revised: 10/2020 Hospira, Inc.

Page 3 of 3 1 2 3

RxDrugLabels.com provides trustworthy package insert and label information about marketed prescription drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by RxDrugLabels.com. Every individual prescription drug label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2021. All Rights Reserved.